MUC16 and ovarian carcinoma: First, we confirmed that cancer antigen 125 (CA-125), a blood marker for ovarian cancer, was significantly elevated in patients with ovarian cancer with successful PDX but not in those with failed PDX (Table 2, p = 0.0216).